Skip to main content

Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market is Expected to Grow Drastically, Assured By Experts From 2023 To 2028

 


Surgical hemostat is a surgical tool used in many surgical procedures to control bleeding. Surgical hemostats covered in this report include thrombin-based, combination hemostats, oxidized regenerated cellulose-based, gelatin-based, and collagen-based. Internal tissue sealants are typically used in surgeries to bind or hold internal tissues such as blood vessels, internal organs, bone cartilage, dura matter and others.

The global surgical hemostats, internal tissue sealants and adhesion barriers market is estimated to account for US$ 4,231.4 Mn in terms of value in 2020 and is expected to reach US$ 7,346.7 Mn by the end of 2027

Global Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market: Drivers

Increasing number of surgical procedures is expected to propel growth of the global surgical hemostats, internal tissue sealants and adhesion barriers market over the forecast period. For instance, according to ‘Surgical operations and procedures statistics’ of Eurostat in November 2019, at least 1.4 million caesarean sections performed in the EU in 2017.

Moreover, high incidence of early postoperative small bowel obstruction is also expected to aid in growth of the market. For instance, according to the study, “Incidence and risk factors of early postoperative small bowel obstruction in patients undergoing hysterectomy for benign indications”, published in the American Journal of Obstetrics and Gynecology, in March 2019, the incidence rate of early small bowel obstructions was 5.9 per 1000 hysterectomies and 43.7% of the study population developed small bowel obstruction during the initial hospital stay and 23.1% underwent reoperation.

High number of cardiovascular procedures is expected to propel growth of the global surgical hemostats, internal tissue sealants and adhesion barriers market over the forecast period. For instance, according to American Heart Association 2019 Heart Disease and Stroke Statistics, 1,016,000 cardiac catheterizations and 3,244 heart transplants were performed in the U.S. in 2014 and 2017, respectively.      

Statistics:

Hemostat held dominant position in the global surgical hemostats, internal tissue sealants and adhesion barriers market in 2019, accounting for 41.1% share in terms of value, followed by Internal Tissue Sealants, and adhesion barriers respectively

 

Labels:

Comments

Post a Comment

Popular posts from this blog

The Global Autoclave Equipment Market Continues To Grow Owing To the Rising Demand from Healthcare Sectors for Sterilizing Medical Equipment to Ensure the Safety of the Post-Surgical Period

  Autoclave equipment is the most popular sterilization method in the industry and is used for many applications including the manufacture of food products. It is widely used in the foodservice industry to sterilize and cleanse equipment used in the process of preparing and serving food. The autoclave is the abbreviated form of autolysis which means oxidation. Autoclaves have various parts including an electric motor, a condenser, and a burner. Autoclave equipment includes vials for sealing the autoclave, a glass or plastic container that has been lined with wax or plastic, and the appropriate autoclave equipment accessories such thermometer for measuring the temperature of the autoclave. All modern steam sterilizing equipment & autoclave machines provide a much-refined workflow experience, which makes you reconsider whether or not steam sterilizing is all it can be. A wide range of sterilization methods is used for sterilizing your medical and laboratory specimen so the right ...
Post a Comment
Read more

Biologics Market Increasing Prevalence of Chronic Diseases to Augment Growth of the market

  A  biologic  drug ( biologics ) is a product that is produced from living organisms or contains components of living organisms.  Biologic  drugs are widely used to prevent, diagnose, treat, or cure a variety of diseases, including infectious diseases, autoimmune disorders, chronic kidney disease, and cancer. Market Dynamics In the recent past, several novel biopharmaceutical products were approved by major regulatory bodies and major players in the market have launched various novel and innovative biopharmaceutical products. Rapid approvals and launches of novel products in the market are expected to be major drivers for growth of the biologicsmarket . 
Post a Comment
Read more

Treprostinil Drugs Market - High Prevalence of Pulmonary Arterial Hypertension and R&D of New Formulations of Treprostinil to Augment Growth of market

  Treprostinil is an antihypertensive agent used to treat patients with pulmonary arterial hypertension. It can also be used in the treatment of Degos disease, an extremely rare disorder in which small and medium sized arteries become blocked (occlusive arteriopathy), restricting the flow of blood to affected areas. Market Dynamics High prevalence of pulmonary arterial hypertension is expected to propel growth of the treprostinil drugs market . For instance, according to the study, ‘High Geographic Prevalence of Pulmonary Artery Hypertension: Associations with Ethnicity, Drug Use, and Altitude’, published in February 2020, in the journal Pulmonary Circulation, the overall pulmonary arterial hypertension incidence was 14 cases per million and the annual period prevalence of pulmonary arterial hypertension was 93 cases per million. Decline in new prescriptions for treprostinil-based products is expected to hinder growth of the treprostinil drugs market. For instance, United The...
Post a Comment
Read more